with those of the controls (ad libitum and pair-fed) (6, 7) . It is generally recognized that postnatal food or nutrient restriction can influence the development of brain and the processes of dendritic extention and myelination (8) (9) (10) (11) . The proliferation of glial cells is also postnatal and occurs throughout the suckling period. The massive increase in glial cell number is followed by the deposition of lipids in the myelin sheath formed by these cells (10, 12) . At this time the neurons grow axons and dendrites and form synaptic interconnections, and the process of myelination is initiated by a rapidly expanding population of glial cells. Lipids are the major constituent of myelin, and there is evidence that most of the proteolipids and glicolipids of brain are localized in myelin (13, 14) .
Therefore, it was considered that nicotinic acid deficiency imposed during the brain growth-spurt led to a deficit in the glial cell population and the capacity to form myelin. This study was made to investigate the role of nicotinic acid in myelination in the brain during the suckling period. We measured the content of DNA, RNA and protein in the brains of developing rats which had received 3 acetylpyridine, pair-fed control and ad libitum control.
METHODS
Animals and diet. Partially modified AIN-76 purified diet was prepared as described by the Council of American Institute of Nutrition (15, 16) ( Table 1) . Composition of the diet is shown in Table 1 . Rats of the Sprague Dawley strain were used. Dams of suckling animals were fed on AIN-76 purified diet from day 14 of gestation and throughout the lactation period ad libitum. Litters were reduced to ten each at birth. Pups of both sexes were used for the experiment. On the 6th day after birth, pups were divided into three groups. Group I was given 3-acetylpyridine (3mg/100g body weight, 0.1% solution) by intraperitoneal injection from the 6th day after birth to one day before autopsy. An equal volume of 0.9% NaCI solution was given Group II and III. Rats were weighed daily and their general condition was Table 3 . A significant difference was found between general growth parameters of ad libitum control and those of rats receiving 3-acetylpyridine and pair-fed control after only 3 days of administration of 3 acetylpyridine. Brain DNA content in the ad libitum control (Group III) followed the normal postnatal developmental pattern of extremely rapid accumulation from 6 days to about 18 days but remained essentially constant thereafter. Rapid accumulation of DNA in the brains of rats receiving 3-acetylpyridine (Group I) and in those of pair-fed control (Group II) did not begin until 12 days of age and continued to approximately 24 days of age. At this state, the brains of the rats receiving 3-acetylpyridine contained 20% less DNA than those of the ad libitum control and the brains of the pair-fed control contained 15% less DNA than those of the ad libitum control at 30 days of age. The RNA content per brain increased with age, reached a maximum on day 12 in the ad libitum control group and then decreased by 20% at 30 days of age. In contrast, the RNA content in the brains of rats receiving 3-acetylpyridine and in those of the pair-fed control peaked about a week later, at 18 days, and remained consistently and significantly lower than that of the control. The peak rate of RNA accumulation was also delayed in the brains of rats receiving 3-acetylpyridine and in those of the pair-fed control and never reached the highest rate found in the ad libitum control. The retardation of development in the brains of rats receiving 3 acetylpyridine and in those of the pair-fed control in the early postnatal period is also clearly demonstrated by the data of protein content.
Protein levels in the brain of rats receiving 3-acetylpyridine were only half those of the ad libitum control values from 12 to 18 days of age. Protein levels in the brain of pair-fed control were slightly higher than those of rats receiving 3-acetylpyridine but were 60% of the ad libitum control values from 12 to 18 days of age. After day 18, protein content in brains of rats receiving 3-acetylpyridine and in those of pair fed control caught up to some extent, the difference in brain protein content at day 30 being 25%. This differential effect of 3-acetylpyridine on the accretion of DNA, RNA and protein in the developing brain is shown clearly in the values for RNA/DNA and protein/DNA at different ages ( Figs. 1 and 2) . The values for RNA/DNA measured in the ad libitum control animals rose sharply until 12 days of age. A decline in the ratio followed until 24 days of age. In the animals receiving 3-acetylpyridine and in the pair-fed control, the peak rate of the ratio for RNA/DNA was depressed, which was followed by a decline in the ratio until 27 days of age. The development pattern of the ratio for protein/DNA differed considerably from that of the ratio for RNA/DNA. In the ad libitum control animals, a 2.2-fold increase in the ratio for protein/DNA was noted between days 6 and 14. In the animals receiving 3 acetylpyridine and in the pair-fed control, a 1.8-fold increase in the ratio was noted between days 6 and 21, and a remarkable increase thereafter.
DISCUSSION
In the present experiment, the composition of the brain of rats receiving 3 acetylpyridine from 6 days to 30 days of age, was compared with that of the control groups. Measurements of brain DNA, RNA and protein content of rats receiving 3 -acetylpyridine suggested the presence of about one week's retardation of brain growth and development compared with ad libitum control. The most striking differences were noted at 12 days of age. These general growth parameters also clearly indicated a delay of one week in the brain development of pair-fed control compared to ad libitum control. On day 12, the brains of rats receiving 3 during the first week after administration of 3-acetylpyridine. During this time, in rats, glial cells rapidly proliferate and develop in proportion to myelination. Measurements of the brain DNA, RNA and protein content of rats receiving 3 acetylpyridine and pair-fed control suggested a retardation of brain growth and development of about one week compared to the ad libitum control with most striking differences noted at 12 days of age. The results of the experiments on general growth parameters suggest that undernourishment from restricted food intake plays an important role in the retardation of brain growth and development rather than 3-acetylpyridine. On the other hand, the reduced myelin yield cannot be attributed to inadequate nutritional intake, as pair-fed rats did not produce myelin deficit nor decrease in brain cerebroside concentration and in CNP specific activity. This suggests that 3-acetylpyridine is responsible for the loss of myelin rather than undernourishment from restricted food intake. Our observations suggest that nicotinic acid can influence myelination through the metabolism of cerebroside which contains long-chain fatty acids.
